Free Trial

Kazia Therapeutics (KZIA) SEC Filings & 10K Form

Kazia Therapeutics logo
$0.88 -0.07 (-7.36%)
Closing price 03/28/2025 03:52 PM Eastern
Extended Trading
$0.89 +0.01 (+1.58%)
As of 03/28/2025 06:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Kazia Therapeutics SEC Filings

DateFilerForm TypeView
03/19/2025
4:25 PM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SCHEDULE 13G/A
03/13/2025
6:00 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2025
5:33 AM
Kazia Therapeutics (Filer)
Form 424B3
02/20/2025
3:53 PM
Kazia Therapeutics (Filer)
Form 424B3
02/20/2025
3:55 PM
Kazia Therapeutics (Filer)
Form 424B3
02/05/2025
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
02/05/2025
3:39 PM
Kazia Therapeutics (Filer)
Form 424B3
02/03/2025
7:36 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
3:31 PM
Kazia Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/30/2025
6:57 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2025
7:02 AM
Kazia Therapeutics (Filer)
Form 424B3
01/30/2025
7:05 AM
Kazia Therapeutics (Filer)
Form 424B3
01/16/2025
9:40 AM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SCHEDULE 13G
01/13/2025
7:00 AM
Kazia Therapeutics (Filer)
Form 424B5
01/13/2025
7:03 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2025
7:05 AM
Kazia Therapeutics (Filer)
Form 424B3
01/13/2025
7:07 AM
Kazia Therapeutics (Filer)
Form 424B3
01/10/2025
7:00 AM
Kazia Therapeutics (Filer)
Form 424B5
12/31/2024
7:46 AM
Kazia Therapeutics (Filer)
Form 424B3
12/31/2024
7:49 AM
Kazia Therapeutics (Filer)
Form 424B3
12/31/2024
7:43 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
8:01 AM
Kazia Therapeutics (Filer)
Form 424B3
12/11/2024
8:04 AM
Kazia Therapeutics (Filer)
Form 424B3
12/11/2024
7:58 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
3:33 PM
Kazia Therapeutics (Filer)
Form 424B3
12/03/2024
3:38 PM
Kazia Therapeutics (Filer)
Form 424B3
12/02/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
12/02/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
11/27/2024
3:30 PM
Kazia Therapeutics (Filer)
Form POS AM
11/27/2024
3:30 PM
Kazia Therapeutics (Filer)
Form POS AM
11/06/2024
6:53 PM
Kazia Therapeutics (Subject)
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
Form SC 13G
11/01/2024
3:05 PM
Kazia Therapeutics (Filer)
Form NT 20-F
10/24/2024
7:28 AM
Kazia Therapeutics (Filer)
Form 424B3
10/24/2024
7:33 AM
Kazia Therapeutics (Filer)
Form 424B3
10/24/2024
7:38 AM
Kazia Therapeutics (Filer)
Form 424B3
10/24/2024
7:22 AM
Kazia Therapeutics (Filer)
Form 6-K/A
10/15/2024
6:01 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
6:03 AM
Kazia Therapeutics (Filer)
Form 424B3
10/15/2024
6:04 AM
Kazia Therapeutics (Filer)
Form 424B3
10/15/2024
6:06 AM
Kazia Therapeutics (Filer)
Form 424B3
10/02/2024
3:52 PM
Kazia Therapeutics (Filer)
Form 424B3
Trump Treasure April 19 (Ad)

Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…

If I’m right about this (like I was before) a modest $900 investment…
10/02/2024
3:55 PM
Kazia Therapeutics (Filer)
Form 424B3
10/02/2024
3:57 PM
Kazia Therapeutics (Filer)
Form 424B3
09/23/2024
8:27 AM
Kazia Therapeutics (Filer)
Form 424B3
09/23/2024
8:23 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
8:25 AM
Kazia Therapeutics (Filer)
Form 424B3
09/23/2024
8:26 AM
Kazia Therapeutics (Filer)
Form 424B3
09/13/2024
8:06 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
8:10 AM
Kazia Therapeutics (Filer)
Form 424B3
09/13/2024
8:12 AM
Kazia Therapeutics (Filer)
Form 424B3
09/13/2024
8:14 AM
Kazia Therapeutics (Filer)
Form 424B3
09/12/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
09/04/2024
7:56 PM
Kazia Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
08/12/2024
6:28 PM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SC 13G/A
07/10/2024
8:26 AM
Kazia Therapeutics (Filer)
Form 424B3
07/10/2024
8:28 AM
Kazia Therapeutics (Filer)
Form 424B3
07/10/2024
8:28 AM
Kazia Therapeutics (Filer)
Form 424B3
07/10/2024
8:19 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
4:29 PM
Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
Form SC 13G
06/28/2024
3:27 PM
Kazia Therapeutics (Filer)
Form 424B3
06/24/2024
7:14 PM
Kazia Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
06/04/2024
11:15 PM
Kazia Therapeutics (Filer)
Form EFFECT
05/29/2024
7:55 AM
Kazia Therapeutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
05/23/2024
6:00 AM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
6:03 AM
Kazia Therapeutics (Filer)
Form 424B3
05/01/2024
3:01 PM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2024
3:06 PM
Kazia Therapeutics (Filer)
Form 424B3
04/19/2024
3:26 PM
Kazia Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
3:30 PM
Kazia Therapeutics (Filer)
Form 424B3
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:KZIA) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners